Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Radioisotope Volume: Production and usage volumes of pharmaceuticals.
5.4 Healthcare Spending: Expenditure data by government, insurers, and out-of-pocket by patients.
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Radiopharmaceuticals Market Segmentation, by Radioisotope
7.1 Chapter Overview
7.2 Iodine I
7.2.1 Iodine I Market Trends Analysis (2020-2032)
7.2.2 Iodine I Market Size Estimates and Forecasts to 2032 (USD Million)
7.3 Gallium 68
7.3.1 Gallium 68 Market Trends Analysis (2020-2032)
7.3.2 Gallium 68 Market Size Estimates and Forecasts to 2032 (USD Million)
7.4 Technetium 99m
7.4.1 Technetium 99m Market Trends Analysis (2020-2032)
7.4.2 Technetium 99m Market Size Estimates and Forecasts to 2032 (USD Million)
7.5 Fluorine 18
7.5.1 Fluorine 18 Market Trends Analysis (2020-2032)
7.5.2 Fluorine 18 Market Size Estimates and Forecasts to 2032 (USD Million)
7.6 Others
7.6.1 Others Market Trends Analysis (2020-2032)
7.6.2 Others Market Size Estimates and Forecasts to 2032 (USD Million)
8. Radiopharmaceuticals Market Segmentation, by Application
8.1 Chapter Overview
8.2 Cancer
8.2.1 Cancer Market Trends Analysis (2020-2032)
8.2.2 Cancer Market Size Estimates and Forecasts to 2032 (USD Million)
8.3 Cardiology
8.3.1 Cardiology Market Trends Analysis (2020-2032)
8.3.2 Cardiology Market Size Estimates And Forecasts To 2032 (USD Million)
8.4 Others
8.4.1 Others Market Trends Analysis (2020-2032)
8.4.2 Others Market Size Estimates And Forecasts To 2032 (USD Million)
9. Radiopharmaceuticals Market Segmentation, by Type
9.1 Chapter Overview
9.2 Diagnostic
9.2.1 Diagnostic Market Trends Analysis (2020-2032)
9.2.2 Diagnostic Market Size Estimates and Forecasts to 2032 (USD Million)
9.3 Therapeutic
9.3.1 Therapeutic Market Trends Analysis (2020-2032)
9.3.2 Therapeutic Market Size Estimates and Forecasts to 2032 (USD Million)
10. Radiopharmaceuticals Market Segmentation, By End User
10.1 Chapter Overview
10.2 Hospitals and Clinics
10.2.1 Hospitals and Clinics Market Trends Analysis (2020-2032)
10.2.2 Hospitals and Clinics Market Size Estimates and Forecasts to 2032 (USD Million)
10.3 Medical Imaging Centers
10.3.1 Medical Imaging Centers Market Trends Analysis (2020-2032)
10.3.2 Medical Imaging Centers Market Size Estimates and Forecasts to 2032 (USD Million)
10.4 Others
10.4.1 Others Market Trends Analysis (2020-2032)
10.4.2 Others Market Size Estimates and Forecasts to 2032 (USD Million)
11. Regional Analysis
11.1 Chapter Overview
11.2 North America
11.2.1 Trends Analysis
11.2.2 North America Radiopharmaceuticals Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
11.2.3 North America Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.2.4 North America Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.2.5 North America Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.2.6 North America Radiopharmaceuticals Market Estimates and Forecasts, By End User (2020-2032) (USD Million)
11.2.7 USA
11.2.7.1 USA Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.2.7.2 USA Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.2.7.3 USA Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.2.7.4 USA Radiopharmaceuticals Market Estimates and Forecasts, By End User (2020-2032) (USD Million)
11.2.8 Canada
11.2.8.1 Canada Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.2.8.2 Canada Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.2.8.3 Canada Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.2.8.4 Canada Radiopharmaceuticals Market Estimates and Forecasts, By End User (2020-2032) (USD Million)
11.2.9 Mexico
11.2.9.1 Mexico Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.2.9.2 Mexico Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.2.9.3 Mexico Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.2.9.4 Mexico Radiopharmaceuticals Market Estimates and Forecasts, By End User (2020-2032) (USD Million
11.3 Europe
11.3.1 Eastern Europe
11.3.1.1 Trends Analysis
11.3.1.2 Eastern Europe Radiopharmaceuticals Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
11.3.1.3 Eastern Europe Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.3.1.4 Eastern Europe Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.3.1.5 Eastern Europe Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.1.6 Eastern Europe Radiopharmaceuticals Market Estimates and Forecasts, By End User (2020-2032) (USD Million)
11.3.1.7 Poland
11.3.1.7.1 Poland Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.3.1.7.2 Poland Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.3.1.7.3 Poland Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.1.7.4 Poland Radiopharmaceuticals Market Estimates and Forecasts, By End User (2020-2032) (USD Million)
11.3.1.8 Romania
11.3.1.8.1 Romania Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.3.1.8.2 Romania Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.3.1.8.3 Romania Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.1.8.4 Romania Radiopharmaceuticals Market Estimates and Forecasts, By End User (2020-2032) (USD Million)
11.3.1.9 Hungary
11.3.1.9.1 Hungary Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.3.1.9.2 Hungary Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.3.1.9.3 Hungary Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.1.9.4 Hungary Radiopharmaceuticals Market Estimates and Forecasts, By End User (2020-2032) (USD Million)
11.3.1.10 Turkey
11.3.1.10.1 Turkey Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.3.1.10.2 Turkey Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.3.1.10.3 Turkey Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.1.10.4 Turkey Radiopharmaceuticals Market Estimates and Forecasts, By End User (2020-2032) (USD Million)
11.3.1.11 Rest of Eastern Europe
11.3.1.11.1 Rest of Eastern Europe Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.3.1.11.2 Rest of Eastern Europe Radiopharmaceuticals Market Estimates and Forecasts, by application (2020-2032) (USD Million)
11.3.1.11.3 Rest of Eastern Europe Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.1.11.4 Rest of Eastern Europe Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.3.2 Western Europe
11.3.2.1 Trends Analysis
11.3.2.2 Western Europe Radiopharmaceuticals Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
11.3.2.3 Western Europe Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.3.2.4 Western Europe Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.3.2.5 Western Europe Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.2.6 Western Europe Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.3.2.7 Germany
11.3.2.7.1 Germany Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.3.2.7.2 Germany Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.3.2.7.3 Germany Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.2.7.4 Germany Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.3.2.8 France
11.3.2.8.1 France Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.3.2.8.2 France Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.3.2.8.3 France Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.2.8.4 France Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.3.2.9 UK
11.3.2.9.1 UK Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.3.2.9.2 UK Radiopharmaceuticals Market Estimates and Forecasts, by application (2020-2032) (USD Million)
11.3.2.9.3 UK Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.2.9.4 UK Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.3.2.10 Italy
11.3.2.10.1 Italy Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.3.2.10.2 Italy Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.3.2.10.3 Italy Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.2.10.4 Italy Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.3.2.11 Spain
11.3.2.11.1 Spain Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.3.2.11.2 Spain Radiopharmaceuticals Market Estimates and Forecasts, by application (2020-2032) (USD Million)
11.3.2.11.3 Spain Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.2.11.4 Spain Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.3.2.12 Netherlands
11.3.2.12.1 Netherlands Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.3.2.12.2 Netherlands Radiopharmaceuticals Market Estimates and Forecasts, by application (2020-2032) (USD Million)
11.3.2.12.3 Netherlands Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.2.12.4 Netherlands Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.3.2.13 Switzerland
11.3.2.13.1 Switzerland Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.3.2.13.2 Switzerland Radiopharmaceuticals Market Estimates and Forecasts, by application (2020-2032) (USD Million)
11.3.2.13.3 Switzerland Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.2.13.4 Switzerland Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.3.2.14 Austria
11.3.2.14.1 Austria Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.3.2.14.2 Austria Radiopharmaceuticals Market Estimates and Forecasts, by application (2020-2032) (USD Million)
11.3.2.14.3 Austria Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.2.14.4 Austria Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.3.2.15 Rest of Western Europe
11.3.2.15.1 Rest of Western Europe Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.3.2.15.2 Rest of Western Europe Radiopharmaceuticals Market Estimates and Forecasts, by application (2020-2032) (USD Million)
11.3.2.15.3 Rest of Western Europe Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.2.15.4 Rest of Western Europe Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.4 Asia Pacific
11.4.1 Trends Analysis
11.4.2 Asia Pacific Radiopharmaceuticals Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
11.4.3 Asia Pacific Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.4.4 Asia Pacific Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.4.5 Asia Pacific Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.4.6 Asia Pacific Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.4.7 China
11.4.7.1 China Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.4.7.2 China Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.4.7.3 China Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.4.7.4 China Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.4.8 India
11.4.8.1 India Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.4.8.2 India Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.4.8.3 India Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.4.8.4 India Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.4.9 Japan
11.4.9.1 Japan Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.4.9.2 Japan Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.4.9.3 Japan Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.4.9.4 Japan Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.4.10 South Korea
11.4.10.1 South Korea Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.4.10.2 South Korea Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.4.10.3 South Korea Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.4.10.4 South Korea Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.4.11 Vietnam
11.4.11.1 Vietnam Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.4.11.2 Vietnam Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.4.11.3 Vietnam Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.4.11.4 Vietnam Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.4.12 Singapore
11.4.12.1 Singapore Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.4.12.2 Singapore Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.4.12.3 Singapore Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.4.12.4 Singapore Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.4.13 Australia
11.4.13.1 Australia Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.4.13.2 Australia Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.4.13.3 Australia Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.4.13.4 Australia Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.4.14 Rest of Asia Pacific
11.4.14.1 Rest of Asia Pacific Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.4.14.2 Rest of Asia Pacific Radiopharmaceuticals Market Estimates and Forecasts, by application (2020-2032) (USD Million)
11.4.14.3 Rest of Asia Pacific Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.4.14.4 Rest of Asia Pacific Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.5 Middle East and Africa
11.5.1 Middle East
11.5.1.1 Trends Analysis
11.5.1.2 Middle East Radiopharmaceuticals Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
11.5.1.3 Middle East Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.5.1.4 Middle East Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.5.1.5 Middle East Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.5.1.6 Middle East Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.5.1.7 UAE
11.5.1.7.1 UAE Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.5.1.7.2 UAE Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.5.1.7.3 UAE Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.5.1.7.4 UAE Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.5.1.8 Egypt
11.5.1.8.1 Egypt Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.5.1.8.2 Egypt Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.5.1.8.3 Egypt Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.5.1.8.4 Egypt Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.5.1.9 Saudi Arabia
11.5.1.9.1 Saudi Arabia Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.5.1.9.2 Saudi Arabia Radiopharmaceuticals Market Estimates and Forecasts, by application (2020-2032) (USD Million)
11.5.1.9.3 Saudi Arabia Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.5.1.9.4 Saudi Arabia Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.5.1.10 Qatar
11.5.1.10.1 Qatar Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.5.1.10.2 Qatar Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.5.1.10.3 Qatar Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.5.1.10.4 Qatar Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.5.1.11 Rest of Middle East
11.5.1.11.1 Rest of Middle East Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.5.1.11.2 Rest of Middle East Radiopharmaceuticals Market Estimates and Forecasts, by application (2020-2032) (USD Million)
11.5.1.11.3 Rest of Middle East Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.5.1.11.4 Rest of Middle East Radiopharmaceuticals Market Estimates and Forecasts, By End User (2020-2032) (USD Million)
11.5.2 Africa
11.5.2.1 Trends Analysis
11.5.2.2 Africa Radiopharmaceuticals Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
11.5.2.3 Africa Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.5.2.4 Africa Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.5.2.5 Africa Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.5.2.6 Africa Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.5.2.7 South Africa
11.5.2.7.1 South Africa Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.5.2.7.2 South Africa Radiopharmaceuticals Market Estimates and Forecasts, by application (2020-2032) (USD Million)
11.5.2.7.3 South Africa Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.5.2.7.4 South Africa Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.5.2.8 Nigeria
11.5.2.8.1 Nigeria Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.5.2.8.2 Nigeria Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.5.2.8.3 Nigeria Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.5.2.8.4 Nigeria Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.5.2.9 Rest of Africa
11.5.2.9.1 Rest of Africa Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.5.2.9.2 Rest of Africa Radiopharmaceuticals Market Estimates and Forecasts, by application (2020-2032) (USD Million)
11.5.2.9.3 Rest of Africa Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.5.2.9.4 Rest of Africa Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.6 Latin America
11.6.1 Trends Analysis
11.6.2 Latin America Radiopharmaceuticals Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
11.6.3 Latin America Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.6.4 Latin America Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.6.5 Latin America Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.6.6 Latin America Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.6.7 Brazil
11.6.7.1 Brazil Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.6.7.2 Brazil Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.6.7.3 Brazil Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.6.7.4 Brazil Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.6.8 Argentina
11.6.8.1 Argentina Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.6.8.2 Argentina Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.6.8.3 Argentina Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.6.8.4 Argentina Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.6.9 Colombia
11.6.9.1 Colombia Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.6.9.2 Colombia Radiopharmaceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.6.9.3 Colombia Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.6.9.4 Colombia Radiopharmaceuticals Market Estimates and Forecasts, By End User(2020-2032) (USD Million)
11.6.10 Rest of Latin America
11.6.10.1 Rest of Latin America Radiopharmaceuticals Market Estimates and Forecasts, by Radioisotope (2020-2032) (USD Million)
11.6.10.2 Rest of Latin America Radiopharmaceuticals Market Estimates and Forecasts, by application (2020-2032) (USD Million)
11.6.10.3 Rest of Latin America Radiopharmaceuticals Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.6.10.4 Rest of Latin America Radiopharmaceuticals Market Estimates and Forecasts, By End User (2020-2032) (USD Million)
12. Company Profiles
12.1 GE Healthcare
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Products/ Services Offered
12.1.4 SWOT Analysis
12.2 Eckert & Ziegler
12.2.1 Company Overview
12.2.2 Financial
12.2.3 Products/ Services Offered
12.2.4 SWOT Analysis
12.3 Curium Pharma
12.3.1 Company Overview
12.3.2 Financial
12.3.3 Products/ Services Offered
12.3.4 SWOT Analysis
12.4 Jubilant Pharmova Limited
12.4.1 Company Overview
12.4.2 Financial
12.4.3 Products/ Services Offered
12.4.4 SWOT Analysis
12.5 Isotopia Molecular Imaging
12.5.1 Company Overview
12.5.2 Financial
12.5.3 Products/ Services Offered
12.5.4 SWOT Analysis
12.6 Novartis AG
12.6.1 Company Overview
12.6.2 Financial
12.6.3 Products/ Services Offered
12.6.4 SWOT Analysis
12.7 NorthStar Medical Radioisotopes
12.7.1 Company Overview
12.7.2 Financial
12.7.3 Products/ Services Offered
12.7.4 SWOT Analysis
12.8 Fusion Pharmaceuticals Inc.
12.8.1 Company Overview
12.8.2 Financial
12.8.3 Products/ Services Offered
12.8.4 SWOT Analysis
12.9 Cardinal Health
12.9.1 Company Overview
12.9.2 Financial
12.9.3 Products/ Services Offered
12.9.4 SWOT Analysis
12.10 Actinium Pharmaceuticals, Inc.
12.10.1 Company Overview
12.10.2 Financial
12.10.3 Products/ Services Offered
12.10.4 SWOT Analysis
13. Use Cases and Best Practices
14. Conclusion
